LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 30.90 | 27.76 | 5 | 2032 | 0.0025 | -0.2417 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 30.90 | 27.76 | 1481 | 2032 | 0.7287 | 0.9004 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 30.90 | 27.76 | 167 | 2032 | 0.0822 | 0.3360 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 30.90 | 27.76 | 1395 | 2032 | 0.6864 | 0.8821 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 32.60 | 27.76 | 8 | 2235 | 0.0036 | -0.1784 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 32.60 | 27.76 | 1548 | 2235 | 0.6924 | 0.8872 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 32.60 | 27.76 | 207 | 2235 | 0.0926 | 0.3734 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 32.60 | 27.76 | 1507 | 2235 | 0.6740 | 0.8792 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 34.30 | 27.76 | 9 | 2449 | 0.0037 | -0.1599 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 34.30 | 27.76 | 1599 | 2449 | 0.6527 | 0.8723 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 34.30 | 27.76 | 237 | 2449 | 0.0967 | 0.3935 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 34.30 | 27.76 | 1642 | 2449 | 0.6703 | 0.8800 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 36.01 | 27.76 | 12 | 2662 | 0.0045 | -0.1196 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 36.01 | 27.76 | 1743 | 2662 | 0.6545 | 0.8753 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 36.01 | 27.76 | 260 | 2662 | 0.0976 | 0.4047 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 36.01 | 27.76 | 1739 | 2662 | 0.6530 | 0.8747 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 37.71 | 27.76 | 15 | 2877 | 0.0052 | -0.0878 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 37.71 | 27.76 | 1914 | 2877 | 0.6651 | 0.8818 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 37.71 | 27.76 | 282 | 2877 | 0.0980 | 0.4137 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 37.71 | 27.76 | 1809 | 2877 | 0.6286 | 0.8660 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 39.41 | 27.76 | 16 | 3105 | 0.0052 | -0.0778 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 39.41 | 27.76 | 2052 | 3105 | 0.6607 | 0.8819 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 39.41 | 27.76 | 338 | 3105 | 0.1088 | 0.4438 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 39.41 | 27.76 | 1968 | 3105 | 0.6337 | 0.8703 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.11 | 27.76 | 21 | 3331 | 0.0063 | -0.0396 | MN20160318_Q01 | I13 |